Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

KORU Medical Systems (KRMD) Net Margin (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Net Margin for 10 consecutive years, with 7.48% as the latest value for Q3 2025.

  • On a quarterly basis, Net Margin rose 1185.0% to 7.48% in Q3 2025 year-over-year; TTM through Sep 2025 was 9.45%, a 2797.0% increase, with the full-year FY2024 number at 18.03%, up 3015.0% from a year prior.
  • Net Margin was 7.48% for Q3 2025 at KORU Medical Systems, down from 1.86% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 1.86% in Q2 2025 to a low of 103.9% in Q4 2023.
  • A 5-year average of 25.9% and a median of 19.54% in 2023 define the central range for Net Margin.
  • Peak YoY movement for Net Margin: crashed -7698bps in 2023, then surged 8627bps in 2024.
  • KORU Medical Systems' Net Margin stood at 16.46% in 2021, then plummeted by -64bps to 26.91% in 2022, then tumbled by -286bps to 103.9% in 2023, then skyrocketed by 83bps to 17.63% in 2024, then skyrocketed by 58bps to 7.48% in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Net Margin are 7.48% (Q3 2025), 1.86% (Q2 2025), and 12.1% (Q1 2025).